Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY: RVTY )

112.26 -0.62 (-0.55%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 Next >
Revvity to Present at Annual Evercore ISI HealthCONx Conference
From Revvity
Via Business Wire
Why Revvity Stock Plunged Today
Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know. 
Via The Motley Fool
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
Earnings Outlook For Revvity
Via Benzinga
What 6 Analyst Ratings Have To Say About Revvity
Via Benzinga
The Latest Analyst Ratings for Revvity
Via Benzinga
Why Biotechnology Company Revvity's Shares Diving Today
Revvity Inc (NYSE: RVTY) shares are trading lower by around 17% after the company reported worse-than-expected Q3 FY23 results and  
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Revvity Announces Financial Results for the Third Quarter of 2023
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Analyst Ratings for Revvity
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Revvity Debuts Inaugural ESG Report
From Revvity
Via Business Wire
Revvity To Hold Earnings Call on Monday, October 30, 2023
From Revvity
Via Business Wire
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure
From Revvity
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
Revvity Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries
From Revvity
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
Revvity to Present at Upcoming September Investor Conferences
From Revvity
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
Revvity Announces Financial Results for the Second Quarter of 2023
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity Accelerates NGS Library Prep with Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC
From Revvity
Via Business Wire
Revvity to Hold Earnings Call on Tuesday, August 1, 2023
From Revvity
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Honeycomb Biotechnologies and Revvity Launch New Solutions to Expand the Frontiers of Single Cell Research
From Revvity
Via Business Wire
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22,  
Via Benzinga
Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
From Revvity
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 35 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.